Compounds > 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-08-23

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Carcinoma

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Carcinoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balbo, S; Hecht, SS; Johnson, CS; Kovi, RC; O'Sullivan, MG1
Dennis, PA; Fox, SD; Kawabata, S; Maier, CR; Memmott, RM; Mercado, JR1
Chung, CJ; Hsueh, YM; Lee, HL; Lin, P; Pu, YS; Shiue, HS; Su, CT; Yang, HY2
Kido, T; Kimura, S; Paiz, J; Vinson, C; Ward, JM; Yoneda, M1
Anderson, MW; Belinsky, SA; Devereux, TR; Foley, JF; Maronpot, RR1

Other Studies

6 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Carcinoma

ArticleYear
Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.
    Toxicologic pathology, 2018, Volume: 46, Issue:2

    Topics: Animals; Carcinogens; Carcinoma; Lung Neoplasms; Male; Nicotiana; Nitrosamines; Pancreatic Neoplasms; Rats; Rats, Inbred F344; Stereoisomerism

2018
Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:9

    Topics: Adenylate Kinase; Administration, Oral; Animals; Antineoplastic Agents; Carcinogens; Carcinoma; Drug Evaluation, Preclinical; Female; Hypoglycemic Agents; Injections, Intraperitoneal; Lung Neoplasms; Metformin; Mice; Nicotiana; Nitrosamines; Signal Transduction; TOR Serine-Threonine Kinases

2010
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    The Science of the total environment, 2011, Apr-01, Volume: 409, Issue:9

    Topics: Biomarkers; Carcinoma; Case-Control Studies; Female; Glucuronides; Humans; Male; Middle Aged; Nitrosamines; Pyridines; Risk Factors; Smoking; Urologic Neoplasms

2011
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
    Toxicology letters, 2013, Jan-10, Volume: 216, Issue:1

    Topics: Aryl Hydrocarbon Hydroxylases; Carcinoma; Case-Control Studies; Female; Gene Expression Regulation, Enzymologic; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Nitrosamines; Pilot Projects; Polymorphism, Genetic; Risk Factors; Smoking; Urologic Neoplasms; Urothelium

2013
Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse.
    Molecular cancer, 2012, Dec-12, Volume: 11

    Topics: Adenoma; Animals; Biomarkers, Tumor; Carcinoma; CCAAT-Enhancer-Binding Proteins; Cell Transformation, Neoplastic; In Situ Nick-End Labeling; Incidence; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Transgenic; Nitrosamines; Pulmonary Alveoli

2012
Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
    Cancer research, 1992, Jun-01, Volume: 52, Issue:11

    Topics: Adenoma; Animals; Carcinogens; Carcinoma; Female; Hyperplasia; Lung; Lung Neoplasms; Mice; Mice, Inbred A; Microscopy, Electron; Nitrosamines; Pulmonary Alveoli; Time Factors

1992